As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Physician Supervision GABAdone is a Medical Food product available by prescription only and must be used while the patient is under ongoing physician supervision
10.1142/S0192415X11008737 97 KiuchiH.TakaoT.YamamotoK.NakayamaJ.MiyagawaY.TsujimuraA.et al (2024)
BMJ Open Sport Exerc Med 2022
Limitations of Current Research Transparency about what we don't know is as important as summarizing what we do know: No FDA approval: CJC-1295 hasn't completed the FDA approval process for any indication
This therapy improves the radiance of your skin, reduces the signs of aging and improves your overall health